Combinations of a potassium channel activator and an mc4r agonist and related methods of use

CO20260008635A2Pending Publication Date: 2026-06-30RHYTHM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
RHYTHM PHARMACEUTICALS INC
Filing Date
2026-06-11
Publication Date
2026-06-30
Patent Text Reader

Abstract

The description refers to a method for treating a disease or disorder in a subject by using a combination of: (i) a potassium channel activator (e.g., a SURx / Kirx channel activating compound) or a pharmaceutically acceptable salt thereof; and (ii) a melanocortin-4 receptor (MC4R) agonist.
Need to check novelty before this filing date? Find Prior Art